SCHEMBL16260993

SCHEMBL16260993

CCN(CC)CCNC(=O)c1cccc(CC(=O)ON2C(=O)CCC2=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.46
▸ GLS O94925 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ GAA P10253 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ NAMPT P43490 1/20 0.44
▸ LMNA P02545 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ SLC22A2 O15244 1/20 0.44
▸ SLC22A1 O15245 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ GFER P55789 1/20 0.43
▸ BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19387274 0.85 ALDH1A1 (0.43) KMT2AGLSMEN1TMEM97SIGMAR1
SCHEMBL17547235 0.82 KMT2A (0.49) KMT2AMEN1TMEM97SIGMAR1GAA
SCHEMBL16260992 0.79 LMNA (0.56) KMT2ATMEM97SIGMAR1ALDH1A1NAMPT
SCHEMBL16260995 0.79 TMEM97 (0.49) KMT2AMEN1TMEM97SIGMAR1GAA
SCHEMBL19634734 0.76 ALDH1A1 (0.58) KMT2AMEN1TMEM97SIGMAR1GAA
SCHEMBL24486817 0.76 KMT2A (0.35) KMT2AALDH1A1HTTTSHRACHE
SCHEMBL19658173 0.76 KMT2A (0.44) KMT2AALDH1A1HPGDMAPK1
SCHEMBL15836548 0.75 ALDH1A1 (0.61) KMT2AMEN1ALDH1A1NAMPTLMNA
SCHEMBL19658177 0.75 KMT2A (0.50) KMT2AALDH1A1HPGDMAPK1
SCHEMBL24487024 0.75 GAA (0.46) KMT2AGLSMEN1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-11-27 — — US disclosed
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 KMT2A 3081/4885GLS 1183/4885MEN1 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback